BC
TAK icon

Bayforest Capital’s Takeda Pharmaceutical TAK Stock Holding History

Bayforest Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.4K Sell
4,453
-5,838
-57% -$96.6K 0.07% 525
2026
Q1 		$191K Sell
10,291
-4,699
-31% -$82.5K 0.21% 138
2025
Q4 		$234K Sell
14,990
-4,764
-24% -$68.1K 0.17% 231
2025
Q3 		$289K Buy
19,754
+3,749
+23% +$55.7K 0.14% 302
2025
Q2 		$247K Buy
+16,005
New +$236K 0.11% 334

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Bayforest Capital's TAK Position: Q2 2026 in Review

Bayforest Capital reduced its Takeda Pharmaceutical (TAK) stake by 57% in Q2 2026, selling an estimated $96.6K and leaving 4,453 shares worth $71.4K. The position accounts for 0.07% of the portfolio, ranked #525.

Bayforest Capital first reported a position in TAK in Q2 2025 and has held it in 5 quarters since. The position peaked at $289K in Q3 2025. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Bayforest Capital held 4,453 shares of Takeda Pharmaceutical worth $71.4K as of Q2 2026.
  • Bayforest Capital sold 5,838 Takeda Pharmaceutical shares in Q2 2026, an estimated $96.6K.
  • Takeda Pharmaceutical made up 0.07% of Bayforest Capital's portfolio in Q2 2026, its #525 holding.
  • Bayforest Capital first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • Bayforest Capital's Takeda Pharmaceutical position peaked at $289K in Q3 2025.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.